Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

LON/0RCQ stock hub

LON/0RCQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RCQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

28.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RCQ

In the news

Latest news · LON/0RCQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-51.2

P25 n/aP50 n/aP75 n/a

ROIC33.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RCQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

EUR

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	5
Employees Change	-6%
Employees Change Percent	-17.65
Enterprise value	EUR 25.7M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Isin	FR0013018124
Last refreshed	2026-05-10
Market cap	EUR 28.9M
Price	EUR 0.38
Price currency	EUR
Rev Per Employee	3,306,048.6x
Sic	2834
Symbol	lon/0RCQ
Website	https://www.nicox.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.29%
EV Earnings	-12.19x
EV/EBIT	4.48x
EV/EBITDA	4.47x
EV/Sales	1.57x
P/B ratio	5.5x
P/S ratio	1.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.99%
EBITDA Margin	35.04%
Gross margin	46%
Gross Profit	EUR 7.6M
Net Income	EUR -2.1M
Pretax Margin	-12.73%
Profit Margin	-12.73%
Profit Per Employee	EUR -420,994
ROA	23.82
Roa5y	-5.71
ROCE	83.67
ROE	-51.16
Roe5y	-76.22
ROIC	33.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-26.42%
Cagr15y	-19.02%
Cagr1y	67.46%
Cagr3y	-13.14%
Cagr5y	-38.22%
Revenue Growth	113.45x
Revenue Growth Q	-11.94x
Revenue Growth3 Y	27.83x
Revenue Growth5 Y	42.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.09
Assets	EUR 9M
Cash	EUR 3.6M
Current Assets	EUR 12M
Current Liabilities	EUR 15.2M
Debt	EUR 352,188
Debt EBITDA	EUR 0.06
Debt Equity	EUR 0.07
Equity	EUR 5.3M
Interest Coverage	2.25
Liabilities	EUR 3.8M
Long Term Assets	EUR -3M
Long Term Liabilities	EUR -11.4M
Net Cash	EUR 3.3M
Net Cash By Market Cap	EUR 11.3
Net Debt EBITDA	EUR -0.56
Net Debt Equity	EUR -0.62
Tangible Book Value	EUR 5.2M
WACC	14.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.17
Net Working Capital	EUR 3.5M
Quick ratio	3
Working Capital	EUR 6.8M
Working Capital Turnover	EUR 3.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-95.35%
1Y total return	67.4%
200-day SMA	0.37
3Y total return	-34.48%
50-day SMA	0.42
50-day SMA vs 200-day SMA	50over200
5Y total return	-91%
All Time High	77.1
All Time High Change	-99.51%
All Time High Date	2008-04-22
All Time Low	0.17
All Time Low Change	130.3%
All Time Low Date	2024-08-05
ATR	0.01
Beta	0.53
Ch YTD	27.3
High	0.38
High52	0.65
High52 Date	2025-08-07
High52ch	-41.54%
Low	0.38
Low52	0.21
Low52 Date	2025-05-15
Low52ch	79.25%
Ma50ch	-8.83%
Price vs 200-day SMA	1.96%
RSI	40.36
RSI Monthly	43.5
RSI Weekly	50.57
Sharpe ratio	0.96x
Sortino ratio	2.03
Tr YTD	27.3
Tr15y	-95.78%
Tr1m	-3.8%
Tr1w	-1.81%
Tr3m	11.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 5.8M
Operating margin	34.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	88,130,706%
Shares Institutions	6.18%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,031.5x
Ch10y	-95.35
Ch15y	-95.78
Ch1m	-3.8
Ch1w	-1.81
Ch1y	67.4
Ch3m	11.77
Ch3y	-34.48
Ch5y	-91
Ch6m	18.57
Change	-1.68%
Change From Open	-0.13
Close	0.39
Days Gap	-1.55
Depreciation Amortization	8,383.9
Dollar Volume	726.2
Earnings Date	2026-05-14
EBIT	EUR 5.8M
EBITDA	EUR 5.8M
F Score	3
Fiscal Year End	December
Founded	1,996
Is Primary Listing	0
Last Earnings Date	2026-01-23
Last Report Date	2025-06-30
Last Split Date	2015-12-03
Last Split Type	Reverse
Ma150	0.37
Ma150ch	4.08%
Ma20	0.4
Ma20ch	-4.62%
Next Earnings Date	2026-05-14
Open	0.38
Position In Range	33.33
Ppne	7,428
Price Date	2026-05-08
Price EBITDA	EUR 4.99
Ptbv Ratio	5.51
Relative Volume	0.38x
Revenue	16,530,243x
Tr6m	18.57%
Volume	1,911

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RCQ pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RCQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RCQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0RCQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.4

Neutral momentum band

Price vs 200-day MA

+2.0%

50/200-day relationship not available

Beta (5Y)

0.53

Less volatile than the market

Sharpe ratio

0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RCQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RCQ stock rating?

lon/0RCQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RCQ analysis?

The full report lives at /stocks/lon/0RCQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RCQ?

The latest report frames lon/0RCQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RCQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.